Letters to the Editor
7 October 2025
Early Access
Resectability in lung cancer: a surgeon’s judgment in the era of the multidisciplinary team
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
41
Views
21
Downloads
Authors
Dear Editor,
The concept of resectability plays a crucial role in determining the operability of non-small cell lung cancer patients...
Altmetrics
Downloads
Download data is not yet available.
Citations
Goldstraw P, Chansky K, Crowley J, et al. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol 2016;11:39-51. DOI: https://doi.org/10.1016/j.jtho.2015.09.009
Furrer K, Weder W, Eboulet E, et al. Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment. J Thorac Cardiovasc Surg 2022;164:1587-602.e5. DOI: https://doi.org/10.1016/j.jtcvs.2022.03.034
Mynard N, Nasar A, Rahouma M, et al. Extent of resection influences survival in early-stage lung cancer with occult nodal disease. Ann Thorac Surg 2022;114:959-67. DOI: https://doi.org/10.1016/j.athoracsur.2022.01.038
Fadel E, Missenard G, Court C, et al. Long-term outcomes of en bloc resection of non-small cell lung cancer invading the thoracic inlet and spine. Ann Thorac Surg 2011;92:1024-30. DOI: https://doi.org/10.1016/j.athoracsur.2011.04.100
Provencio M, Nadal E, Insa A, et al. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial. Lancet Oncol 2020;21:1413-22. DOI: https://doi.org/10.1016/S1470-2045(20)30453-8
D'Amours M, Wu FTH, Theisen-Lauk O, et al. Surgically resectable non-small cell lung cancer: a contemporary approach. Eur Respir J 2024;64:2400332. DOI: https://doi.org/10.1183/13993003.00332-2024
Kim S, Cooke D, Kidane B, et al. The Society of Thoracic Surgeons expert consensus on the multidisciplinary management and resectability of locally advanced non-small cell lung cancer. Ann Thorac Surg 2025;119:16-33. DOI: https://doi.org/10.1016/j.athoracsur.2024.09.041
Zaidi M, Wright G. Locally advanced non-small cell lung cancer: the place of specialist thoracic surgery in the multidisciplinary team. Transl Lung Cancer Res 2020;9:1680-9. DOI: https://doi.org/10.21037/tlcr.2019.11.22
Ray M, Akinbobola O, Fehnel C, et al. Surgeon quality and patient survival after resection for non–small-cell lung cancer. J Clin Oncol 2023;10;41:3616-28. DOI: https://doi.org/10.1200/JCO.22.01971
Birkmeyer JD, Stukel TA, Siewers AE, et al. Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117-27. DOI: https://doi.org/10.1056/NEJMsa035205
How to Cite
“Resectability in Lung Cancer: A surgeon’s Judgment in the Era of the Multidisciplinary Team”. 2025. Monaldi Archives for Chest Disease, October. https://doi.org/10.4081/monaldi.2025.3553.
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.